Biomarkers of hepatotoxicity in rats induced by aqueous extract of Dictamni Cortex based on urine metabolomics.
10.19540/j.cnki.cjcmm.20250222.203
- Author:
Hui-Juan SUN
1
;
Rui GAO
1
;
Meng-Meng ZHANG
1
;
Ge-Yu DENG
1
;
Lin HUANG
1
;
Zhen-Dong ZHANG
1
;
Yu WANG
2
;
Fang LU
2
;
Shu-Min LIU
2
Author Information
1. Graduate School, Heilongjiang University of Chinese Medicine Harbin 150040, China.
2. Research Institute of Chinese Medicine, Heilongjiang University of Chinese Medicine Harbin 150040, China.
- Publication Type:Journal Article
- Keywords:
Dictamni Cortex;
biomarker;
hepatotoxicity;
non-targeted urine metabolomics
- MeSH:
Animals;
Male;
Rats, Sprague-Dawley;
Rats;
Metabolomics;
Biomarkers/metabolism*;
Liver/metabolism*;
Drugs, Chinese Herbal/adverse effects*;
Female;
Chemical and Drug Induced Liver Injury/metabolism*;
Glutathione/metabolism*;
Humans
- From:
China Journal of Chinese Materia Medica
2025;50(9):2526-2538
- CountryChina
- Language:Chinese
-
Abstract:
This paper aimed to use non-targeted urine metabolomics to reveal the potential biomarkers of toxicity in rats with hepatic injury induced by aqueous extracts of Dictamni Cortex(ADC). Forty-eight SD rats were randomly assigned to a blank group and high-dose, medium-dose, and low-dose ADC groups, with 12 rats in each group(half male and half female), and they were administered orally for four weeks. The hepatic injury in SD rats was assessed by body weight, liver weight/index, biochemical index, L-glutathione(GSH), malondialdehyde(MDA), and pathological alterations. The qPCR was utilized to determine the expression of metabolic enzymes in the liver and inflammatory factors. Differential metabolites were screened using principal component analysis(PCA) and partial least squares-discriminant analysis(PLS-DA), followed by a metabolic pathway analysis. The Mantel test was performed to assess differential metabolites and abnormally expressed biochemical indexes, obtaining potential biomarkers. The high-dose ADC group showed a decrease in body weight and an increase in liver weight and index, resulting in hepatic inflammatory cell infiltration and hepatic steatosis. In addition, this group showed elevated levels of MDA, cytochrome P450(CYP) 3A1, interleukin-1β(IL-1β), and tumor necrosis factor-α(TNF-α), as well as lower levels of alanine transaminase(ALT) and GSH. A total of 76 differential metabolites were screened from the blank and high-dose ADC groups, which were mainly involved in the pentose phosphate pathway, tryptophan metabolism, purine metabolism, pentose and glucuronic acid interconversion, galactose metabolism, glutathione metabolism, and other pathways. The Mantel test identified biomarkers of hepatotoxicity induced by ADC in SD rats, including glycineamideribotide, dIDP, and galactosylglycerol. In summary, ADC induced hepatotoxicity by disrupting glucose metabolism, ferroptosis, purine metabolism, and other pathways in rats, and glycineamideribotide, dIDP, and galactosylglycerol could be employed as the biomarkers of its toxicity.
